Larotrectinib 100mgCapsule
Anti-Cancer

Larotrectinib 100mg

Larotrectinib Sulfate

First-in-class selective TRK inhibitor for NTRK gene fusion-positive solid tumors regardless of tumor type, representing tissue-agnostic oncology therapy. Manufactured by Indian generic companies for oncology export.

Strengths

25mg / 100mg

Packing

56 capsules/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Larotrectinib Sulfate 25mg / 100mg
Dosage Form
Capsule
Available Strengths
25mg / 100mg
Packing
56 capsules/bottle
Route of Administration
Oral, with or without food
Dosage
100mg twice daily until disease progression or unacceptable toxicity
Indications
NTRK gene fusion-positive solid tumors that are metastatic or where surgical resection is likely to result in severe morbidity
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 20-25°C
Shelf Life
36 months
Side Effects
Fatigue, nausea, dizziness, vomiting, increased AST/ALT, cough, constipation, diarrhea
Precautions
Confirm NTRK gene fusion by validated test before use; neurotoxicity monitoring; hepatotoxicity monitoring; dose reduction for CYP3A4 inhibitors

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Sorafenib 200mgTablet

Sorafenib 200mg

Sorafenib Tosylate

Soranib (Sorafenib 200mg) is an oral anti-cancer medicine that works by blocking abnormal protein signals that cause cancer cells to multiply. It helps stop or slow the spread of cancer in hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma. Available for global pharmaceutical export with WHO-GMP certification.

200mg
Lenalidomide 25mgCapsule

Lenalidomide 25mg

Lenalidomide

Lenalid (Lenalidomide 25mg) is an anti-cancer medicine that works by enhancing the immune system to attack cancer cells while preventing growth of new blood vessels within tumors. It is used for treatment of multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. Available in 5mg, 10mg, and 25mg capsule strengths for global pharmaceutical export.

5mg / 10mg / 25mg
Imatinib 400mgTablet

Imatinib 400mg

Imatinib Mesylate

First-in-class BCR-ABL tyrosine kinase inhibitor that transformed CML from a fatal disease into a chronically manageable condition, achieving complete cytogenetic response in over 80% of newly diagnosed chronic-phase patients. It also targets c-KIT and PDGFR, making it the standard first-line treatment for unresectable or metastatic GIST and Ph+ ALL. Cipla and Sun Pharma manufacture affordable Indian generics in both 100mg and 400mg tablet strengths exported to oncology programmes worldwide.

100mg / 400mg

Need bulk pricing for Larotrectinib 100mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote